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Abstract 
Background: Breast cancer is the most common cancer in women worldwide. Although adjuvant therapy after 
breast-conserving surgery or mastectomy reduces the risk of breast cancer coming back but it induces many of 
physiological and psychological effects. The aim of the current study was to compare the Symptoms-related 
distress among patients receiving adjuvant therapy: Radical Mastectomy versus Lumpectomy at a University 
Hospital. Research Questions: Q1: What are the symptoms related distresses among radical mastectomy and 
lumpectomy patients receiving adjuvant therapy? Q2: Is there a difference in symptoms related distress between 
radical mastectomy and lumpectomy patients receiving adjuvant therapy? Design: A comparative descriptive -
non-experimental design was utilized to achieve the aim of the current study. Tools: I) Socio-demographic and 
medical data sheet: It included data related to the studied subjects such as age, gender, marital status, types of 
received chemotherapy,…..etc. Tool II: Rotterdam Symptom Checklist (RSCL); it is useful in measuring the 
symptoms reported by cancer patients. It aims to enhance the insight into the consequences of the disease and its 
treatment. Setting: The study was conducted at the Nuclear Medicine Unit at Kasr Al-Aini Educational Hospital; 
affiliated to Cairo-University-Egypt. Subjects: A convenient sample of 60 adult female patients divided into two 
equal groups, patients with radical mastectomy (n=30) and patients with lumpectomy (n=30) both groups 
received chemotherapy after surgery. Results: 80% of mastectomy and lumpectomy cases overall their age was 
between 40 and less than 60 years old. 33.3% of the study sample can read and write. The study pointed out that 
48.3% of the sample had breast cancer between 2 and less than 6 months. While 50% of them between 6 to less 
than 12 months with Mean+SD= 5.65+2.There was a perfect correlation between total score of RSCL and 
physical total score =0.826, 0.829 & 0.828 for patients overall cases, mastectomy cases only & lumpectomy 
cases only respectively. Also there was a strong correlation between the RSCL total score and psychological 
total score=0.705, 0.747 & 0.668 for the patients overall cases, mastectomy cases only & lumpectomy cases only 
respectively. Conclusion: The lumpectomy cases scored generally their physical, psychological & activity level 
impairment status much better than the mastectomy cases. Also lumpectomy cases their general QOl was better 
than the mastectomy cases. Recommendation of the study: 1-More close physical, psychological support must 
endorse in nursing care for patients with mastectomy. 2-QOL advanced tool is recommended on survey scale to 
evaluate patients' condition with mastectomy & lumpectomy. 3-All patients with breast cancer must join a 
rehabilitation program before & after proceed in either mastectomy or lumpectomy surgical management. 
Keywords: Adjuvant therapy, Mastectomy, lumpectomy, symptoms related distress. 
 
Introduction: 
Breast cancer, is the most common and serious problem among women worldwide. Nearly 1.7 million new cases 
diagnosed in 2012 (second most common cancer overall). This represents about 12% of all new cancer cases and 
25% of all cancers in women. The primary treatment modalities of breast cancer include surgical excision, 
radiation therapy (RT), surgery with concurrent chemoradiation therapy (CCRT), and hormone therapy (Liao, 
et.al, 2015). Depending on the stage and type of the tumor, lumpectomy (removal of the lump only), or surgical 
removal of the entire breast (mastectomy) is performed  (Sharma,  Dave, Sanadya, Sharma & Sharma, 2010). 
Despite surgery is the essential management for breast cancer, the adjuvant therapies such as chemotherapy and 
radiotherapy are commonly used postoperatively with the purpose of inhibits metastasis and improves long-term 
survival rates. As well after lumpectomy surgery, patients typically need five to seven weeks of radiation 
therapy, five days per week, to destroy any cancer cells (Kummerow,   Penson, Yu Shyr, & Hooks, 2015).  Also 
Wang, et-al, (2015) added that breast conservative treatment in capable patients is as effective as Modified 
radical Mastectomy with respect to local tumor control.  
Surviving breast cancer need to significant prolonged treatment by adjuvant therapy primarily radiation, 
chemotherapy and hormone therapy. These treatments, even though increasingly effective in improving patient 
survival intervals, but they are toxic in several ways and produce negative short- and long-term physiological 
and psychological effects including pain, decreased cardio respiratory fitness; cancer related fatigue, reduced 
daily activities and suppressed immune function (Rajarajeswaran, Vishnupriya, 2009). Virtually all cancer 
survivors experience several adverse physiological and psychological symptoms and side-effects related to the 
disease or its treatment (Brown, et al., 2012). Treatment-related symptoms, mood distress, reduced physical 
activity and/or patients' physically inactive during and after cancer treatment considered as the main problems 
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are faced with cancer patients (Yang, Tsai, Huang & Lin, 2011). 
Furthermore, patients with breast cancer in the diagnostic stage, awaiting treatment, or during the 
treatment stage, may encounter a wide range of physical and psychosocial distress symptoms. Symptom distress 
is defined as “the degree of discomfort reported by patients in relation to their perceptions of the symptoms 
being experienced. Breast cancer patients undergoing cancer-related treatment might experience various 
distressful symptoms, such as musculoskeletal pain, headache, loss of energy, impaired limb movement, 
cognitive disturbances, changed sexual experience, lymphedema, upper body symptoms, weight problems, and 
nausea.  In addition, fatigue was the most commonly reported symptom in breast cancer patients undergoing 
chemotherapy that can range from mild lethargy to feeling of completely wiped out and more likely to interfere 
with quality of patients' sleep (Liao, et.al, 2015). Apparently physical, psychological and social disabilities are 
worthy problems for patients undergoing cancer treatment either surgeries or/and adjuvant therapy. For that 
reason, practitioners of physical medicine and rehabilitation need to respond enthusiastically both to disease 
progression and various treatment that may contribute to impairments, disabilities, and handicaps, be it 
physiological or psychological in nature (Thomas & Pandey, 2012). 
In spite of the important role of the oncology nurse in the rehabilitation of the patients with cancer as 
they frequently provide case-management, patient education services and facilitate support to maintain patient's 
optimal independent functioning; they need to devote their attention on the assessment of not only psychosocial 
symptoms related distress as most of research focus but also to focus on the physical symptoms as well; in both 
mastectomy and lumpectomy patients; therefore the aim of the current study was to compare the symptoms-
related distress among patients receiving adjuvant therapy: radical mastectomy versus lumpectomy. 
 
Significance of the study 
Apparently cancer breast becomes one of the most common risky diseases all over the world as it is the most 
widespread type of cancer among women. Recently Fouladi, Poirfarzi, Mohammadi, Masumi, Mohammadi & 
Mazaheri (2013) reported that breast cancer is the highest ranked disease after lung cancer, moreover it is the 
most prevalent cause of cancer death in females. Also it is the major reason of cancer death in 20-59 aged 
women and the incidence rate for breast cancer in the studies undertaken around the world has been reported as 
12.5%). 
Additionally in Egypt,  Ibrahim,   Khaled,  Mikhail,  Baraka & Kamel, (2014) mentioned that incidence 
rates of cancer were calculated at a regional and a national level and revealed that age-standardized incidence 
rates per 100,000 were 166.6 (for both gender), 175.9 (males), and 157.0 (females). Commonest cancer sites 
have been ranked as follows; liver (33.6%) and bladder (10.7%) among men, while breast (32.0%) and liver 
(13.5%) among women. These data is the cancer rates at national and regional levels of Egypt.  
On the other hand; mastectomy and/or lumpectomy are inevitable surgical management in several cases 
with breast cancer and all these cases are in need to receive adjuvant treatment as chemotherapeutic agent after 
the surgical treatment which increases their both physical and psychological suffering.  In particular a lot of 
nursing research studies was focusing mainly on the patients with mastectomy from the psychological 
perspective. So it was crucial to dig down through this area on two levels; firstly: In order to find general 
preview about patients with breast cancer receiving both surgical and adjuvant treatment. Secondly: Comparing 
between mastectomy and lumpectomy cases to highlight differences between their physical and psychological 
complains. Thus, hopefully the current research highlights the symptoms-related distress among patients 
receiving adjuvant therapy; focusing on radical mastectomy versus lumpectomy. 
 
Subjects & Methods 
Aim of the study 
The aim of the current study was to compare the symptoms-related distress among patients receiving adjuvant 
therapy: radical mastectomy versus lumpectomy at a University Hospital. 
 
Research questions 
1. What are the symptoms related distresses among radical mastectomy and lumpectomy patients 
receiving adjuvant therapy? 
2. Is there a difference in symptoms related distress between radical    mastectomy and 
lumpectomy patients receiving adjuvant therapy? 
 
Theoretical definition 
Adjuvant therapy: Means additional cancer treatment given after the primary treatment to lower the 
risk that the cancer will come back. Adjuvant therapy may include chemotherapy, radiation therapy, 
hormone therapy, targeted therapy, or biological therapy. (American National Cancer Institute, 2016). 
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Operational definition 
Patients undertaking adjuvant therapy: For the current study the researchers defined the patients 
with adjuvant therapy are the breast cancer female patients who are undertaking chemotherapy after 
surgical management (mastectomy and lumpectomy). 
 
Research design  
A comparative descriptive -non-experimental design was utilized to guide and achieve the aim of the current 
research.   
 
Setting 
The study was conducted at the Nuclear Medicine Unit at Kasr Al-Aini Educational Hospital; affiliated to Cairo-
University-Egypt. 
 
Subjects 
A convenient sample of 60 adult female breast cancer patients who fit the inclusion criteria was recruited. The 
inclusion criteria were as follows: 1) Patients with radical mastectomy and lumpectomy. 2) Received 
chemotherapy after performed the surgical management. The sample divided into two equal groups, patients 
with radical mastectomy (n=30) and patients with lumpectomy (n=30). 
 
Tools 
In order to accomplish the purpose of the research two tools were utilized in the current study as follows: 
Tool I: Socio-demographic and medical data sheet: It included data related to the studied subjects such 
as age, gender, marital status, occupation & primary/secondary cancer, types of received chemotherapy, sine 
when had breast cancer…..etc. 
Tool II: Rotterdam Symptom Checklist (RSCL) Haes, Olschewski, Fayers, Visser, Cull, Hopwood & 
Sanderman (2012). RSCL tool was useful in measuring the symptoms reported by cancer patients. It aims to 
enhance the insight into the consequences of the disease and its treatment, indicate groups of patients at risk for 
developing high levels of distress, and enable the comparison of the effectiveness of different treatment 
modalities or care programs, and thus support decision making in clinical oncology. The RSCL was designed to 
cover, originally, four domains: physical symptom distress, psychological distress, activity level and overall 
global life quality. The physical symptom distress scale consists of 23 items referring to different physical 
symptoms. Some symptoms such as headaches or fatigue may be experienced by people in general as well as by 
cancer patients. Other symptoms are more specifically related to cancer or cancer treatment: e.g. gastro-intestinal 
and chemotherapy related symptoms…etc. It was scaled from (1 to 4); scored as following   (1= Not at all: up to 
23,   2= A little: up to 46,   3= Quite a bit: up to 69 & 4= Very much: up to 92). The psychological distress scale 
consists of 7 items regarding different symptoms that may be experienced by cancer patients as well as in other 
populations. None of these items refers to psychological symptoms that might be considered ‘psychosomatic’ 
(e.g. headaches or sleeping problems…etc). It was scaled from (1 to 4) scored as following (1= Not at all: up to 
7,   2= A little: up to 14,   3= Quite a bit: up to 21 & 4= Very much: up to 28). Total RSCL score is the 
summation of physical & psychological distress scales only and its score is based on the following interpretation:  
(1= Unable: up to 30, 2= only with help: up to 60, 3= without help but with difficulty: up to 90 & 4= without 
help: up to 120). While the activity level Impairment scale consists of 8 items regarding functional status. These 
items form a scale in which mobility as well as social and role activities are covered. The scale is not related to 
cancer specifically so the owner of the tool did not add it to the overall RSCL score. It was scaled from (1 to 4) 
scored as following (1= Unable: up to 8,  2= only with help: up to 16,  3= without help but with difficulty: up to 
24 & 4= without help: up to 32). And general quality of life (sometimes called either global quality of life or the 
overall evaluation of life) is measured by one single item included in the checklist. The item is derived from 
research in the quality of life of the population in general. An affective operationalisation was chosen for this 
item as such approach proved, in line with theory, more sensitive to clinical change. Each patient selects only 
one of the following (excellent, good, moderately good, neither good nor bad, rather poor, poor & extremely 
poor) which ranged from (1 to 7). The RSCL had an established reliability based on Bijur, Latimer & Gallagher 
(2003) as it was pertain to (physical, psychological, activity level) scales which have adequate reliabilities 
establishing based on the internal consistency (Cronbach’s alpha) of a scale (0.83, 0.87 & 0.88 respectively). 
 
Ethical consideration 
An official permission was taken from the hospital administrators. Each participant was informed about the 
nature and the purpose of the study. Then consent was obtained from all patients for participation in the study. 
The researchers emphasized that participation in the study is entirely voluntary; anonymity and confidentiality 
are assured through coding the data.  
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Pilot study 
Once permission was granted to proceed with the proposed study, a pilot study was carried out before starting 
data collection on 10 of the targeted patients as follows: (5 mastectomy & 5 lumpectomy) patients to evaluate the 
clarity, feasibility and applicability of the tools as well as estimate the time needed to collect data. Also panel of 
juries' expertise were review the tools for its validity. No tool modification was needed.  
 
Procedure   
Once official permission was established from the head of the Nuclear Medicine; the researchers was started in 
data collection initiation. Inclusion criteria: female adult patients who their age was over 18 years old, had 
lumpectomy or mastectomy, scheduled on the same chemotherapy regimen after the surgical procedure. In the 
current study the researchers divided the sample into 30 patients per group as one group was diagnosed with 
lumpectomy and the other group was diagnosed with mastectomy. Patients who fulfilled the inclusion criteria 
were interviewed individually. The tool was filling by the researchers. Firstly the researcher started by the Socio-
demographic and medical data sheet; then was followed by Rotterdam Symptom Checklist (RSCL). Each 
interview obtained around 20 minutes. 
 
Statistical analysis 
The data was coded and tabulated using a personal computer. Statistical Package for Social Science (SPSS) 
version 18 was utilized. Data was presented using descriptive statistics in the form of frequencies and 
percentage. Inferential statistics as compare of means, correlation were utilized. Statistical significance was 
considered at p-value ≤ 0.05. 
 
Results: 
The results will be presented into two sections: I) Description of the study subjects’ social characteristics and the 
medical related data (tables 1&2). While section II represents; A-Description of RSCL (physical, psychological, 
activity level impairment & general QOL) (table, 3). B-Comparative correlation result of RSCL for mastectomy 
versus lumpectomy patients regarding the following perspectives: (physical, psychological, activity level 
impairment & general QOL) (table, 4). 
 
Section I: 
Table 1: 
Description of the study subjects' social characteristics (Mastectomy versus lumpectomy patients) (n=60); 
(30/each). 
Socio-Demographic data Mastectomy & Lumpectomy overall cases 
(n=60) 
Mastectomy Cases only 
(n=30) 
Lumpectomy Cases only 
(n=30) 
No. % No. % No. % 
Age: 
  -20->30 
  -30->40 
  -40->50 
  -50-60 
Mean+SD 45.7+7.7 Mean+SD 46.7 +7.2 Mean+SD 44.7+8.1 
2 
9 
27 
22 
3.3% 
15% 
45% 
36.7% 
0 
3 
16 
11 
0% 
10% 
53.3% 
36.6% 
2 
6 
11 
11 
6.7% 
20% 
36.7% 
36.7% 
Total 60 100% 30 100% 30 100% 
Marital Status: 
  -Single 
  -Married 
  -Widowed 
  -Divorced 
 
2 
46 
11 
1 
 
3.3% 
76.7% 
18.3% 
1.7% 
 
0 
26 
3 
1 
 
0% 
86.7% 
10% 
3.3% 
 
2 
20 
8 
0 
 
6.7% 
66.7% 
26.7% 
0% 
Total 60 100% 30 100% 30 100% 
Educational level: 
-Cannot read or write 
-Read & write 
-Primary 
-Preparatory 
-Secondary 
 
17 
20 
12 
5 
6 
 
28.3% 
33.3% 
20% 
8.3% 
10% 
 
8 
12 
6 
1 
3 
 
26.7% 
40% 
20% 
3.3% 
10% 
 
9 
8 
6 
4 
3 
 
30% 
26.7% 
20% 
13.3% 
10% 
Total 60 100% 30 100% 30 100% 
Occupation: 
  -House wife 
  -Worker 
  -Employee 
  -Farmer 
 
52 
2 
2 
4 
 
86.7% 
3.3% 
3.3% 
6.7% 
 
27 
1 
0 
2 
 
90% 
3.3% 
0 
6.7% 
 
25 
1 
2 
2 
 
83.3% 
3.3% 
6.7% 
6.7% 
Total 60 100% 30 100% 30 100% 
Number of person lives with: 
  -1->3 
  -3-≥5 
 
 
15 
45 
 
 
25% 
75% 
 
 
9 
21 
 
 
30% 
70% 
 
 
6 
24 
 
 
20% 
80% 
Total 60 100% 30 100% 30 100% 
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It was observed that age Mean+SD= 45.7+7.7, 46.7 +7.2 & 44.7+8.1 of the patients with both 
mastectomy and lumpectomy, mastectomy cases only & lumpectomy cases only respectively. Regarding their 
marital status 86.7%, 76.7% & 66.7% was married; while 33.3%, 40% & 26.7% could read and write; 
concerning patients' occupation 86.7%, 90% & 83.3% was house wife and 75%, 70% & 80% was living with not 
less than three members at one place for the patients with both mastectomy and lumpectomy, mastectomy cases 
only & lumpectomy cases only respectively..  
Table 2: 
Description of the study subjects’ medical related data (Mastectomy versus lumpectomy patients) (n=60) 
(30/each). 
Socio-Demographic data Mastectomy & Lumpectomy 
overall cases (n=60) 
Mastectomy Cases 
only (n=30) 
Lumpectomy Cases 
only (n=30) 
No. % No. % No. % 
Since when had cancer: 
 -2->6 (Months) 
 -6->12 (Months) 
 -12-≥14 (Months) 
Mean+SD 5.65+2 Mean+SD 5.77+1.7 Mean+SD 5.53+2.2 
29 
30 
1 
48.3% 
50% 
1.7% 
12 
18 
0 
40% 
60% 
0% 
17 
12 
1 
56.7% 
40% 
3.3% 
Total 60 100% 30 100% 30 100% 
Chemotherapy: 
-Doxorobcin 
-5-Flurouracil 
-Cyclophosphamide 
-Taxol 
-Carboplatin 
Mean+SD 2.4+0.58 Mean+SD 2.3+0.60 Mean+SD 2.4+0.57 
29 
27 
27 
31 
28 
48.3% 
45% 
45% 
51.7% 
46.7% 
13 
12 
12 
17 
15 
43.3% 
40% 
40% 
56.7% 
50% 
16 
15 
15 
14 
13 
53.3% 
50% 
50% 
46.7% 
43.3% 
Other taken medications: 
-Zofran 
-Zantac 
-Decadron 
-Avil 
Mean+SD 3.4+0.48 Mean+SD 3.4+0.49 Mean+SD 3.3+0.48 
60 
58 
60 
23 
100% 
96.7% 
100% 
38.3% 
30 
29 
30 
12 
100% 
96.7% 
100% 
40% 
30 
29 
30 
11 
100% 
96.7% 
100% 
36.7% 
*Total is not mutually exclusive for chemotherapy & antiemetic. 
Regarding patients' period of having cancer it was with a Mean+SD=5.65+2,  5.77+1.7 & 5.53+2.2 with 
percentage of 50%, 60% & 40% of having cancer which was between 6->12 (Months). While for the taken 
chemotherapy was 51.7%, 56.7% & 46.7 with a Mean+SD=2.4+0.58, 2.3+0.60 & 2.4+0.57 was taking taxol. 
And regarding receiving other medications; it was with a Mean+SD=3.4+0.48, 3.4+0.49 & 3.3+0.48 and with 
percentage of 96.7%, 96.7% & 96.7% who are taking zantac' for the patients with overall mastectomy and 
lumpectomy cases, mastectomy cases only & lumpectomy cases only respectively. 
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Section II: 
Table 3: 
Comparative description of RSCL (physical, psychological, activity level impairment & general QOL) 
result among patients with mastectomy and lumpectomy (n=60) (30/each). 
Socio-Demographic data Mastectomy & Lumpectomy 
Cases overall (n=60) 
Mastectomy Cases 
only (n=30) 
Lumpectomy Cases 
only (n=30) 
No. % No. % No. % 
Total Physical Score: 
-Not at all:   (up to 23) 
-A little:       (up to 46) 
-Quite a bit:  (up to 69) 
-Very much: (up to 92) 
Mean+SD 49.6+5.5 Mean+SD 49.9+5.2 Mean+SD 49.3+5.8 
0 
19 
41 
0 
0% 
31.7% 
68.3% 
0% 
0 
6 
24 
0 
0% 
20% 
80% 
0% 
0 
13 
17 
0 
0% 
43.3% 
56.7% 
0% 
Total 60 100% 30 100% 30 100% 
Total Psychological  
Score: 
-Not at all:    (up to 7) 
-A little:       (up to 14) 
-Quite a bit:  (up to 21) 
-Very much: (up to 28) 
Mean+SD 14.4+4.4 Mean+SD 14+4.4 Mean+SD 14.8+4.4 
 
7 
26 
30 
0 
 
6.7% 
43.3% 
50% 
0% 
 
3 
10 
17 
0 
 
10% 
33.3% 
56.7% 
0% 
 
1 
16 
13 
0 
 
3.3% 
53.3% 
43.3% 
0% 
Total 60 100% 30 100% 30 100% 
Total RSCL Score: 
-Not at all:     (up to 30) 
- A little:       (up to 60) 
- Quite a bit:  (up to 90) 
- Very much: (up to 120) 
Mean+SD 64+7.6 Mean+SD 63.8+7.6 Mean+SD 64.1+7.8 
0 
16 
44 
0 
0% 
26.7% 
73.3% 
0% 
0 
9 
21 
0 
0% 
30% 
70% 
0% 
0 
7 
23 
0 
0% 
23.3% 
76.7% 
0% 
Total 60  30 100% 30 100% 
Activity Level 
Impairment: 
-Unable:          (up to 8) 
-With help:      (up to 16) 
-Without help but with 
difficulty:        (up to 24) 
-Without help: (up to 32) 
Mean+SD 20.4+5.9 Mean+SD 20.1+5.8 Mean+SD 20.7+6.1 
 
0 
20 
17 
 
23 
 
0% 
33.3% 
28.3% 
 
38.3% 
 
0 
13 
6 
 
11 
 
0% 
43.3% 
20% 
 
36.7% 
 
0 
7 
11 
 
12 
 
0% 
23.3% 
36.7% 
 
40% 
Total 60 100% 30 100% 30 100% 
General QOL: 
-Excellent=1 
-Good=2 
-Moderately good=3 
-Neither good nor bad=4 
-Rather poor=5 
-Poor=6 
-Extremely poor=7 
 
0 
0 
24 
31 
4 
1 
0 
 
0% 
0% 
40% 
51.7% 
6.7% 
1.7% 
0% 
 
0 
0 
6 
20 
4 
0 
0 
 
0% 
0% 
20% 
66.7% 
13.3% 
0% 
0% 
 
0 
0 
18 
11 
0 
1 
0 
 
0% 
0% 
60% 
36.7% 
0% 
3.3% 
0% 
Total 60 100% 30 100% 30 100% 
Patients' physical score Mean+SD=49.6+5.5, 49.9+5.2 & 49.3+5.8; with 68.3%, 80% & 56.7% was at 
the level of quite a bit. While for the psychological score was found that Mean+SD=14.4+4.4, 14+4.4 & 
14.8+4.4 with 50%, 56.7%  was also at the level of quite a bit & 53.3% at the level of a little . Regarding total 
RSCL it was with Mean+SD= 64+7.6, 63.8+7.6 & 64.1+7.8 and the highest percentage was 73.3%, 70% & 
76.6% at the level of quite a bit as well. Activity of level impairment found with Mean+SD= 20.4+5.9, 20.1+5.8 
& 20.7+6.1 with percentage of 33.3%, 43.3% could do the activity but with help & 40% could do the activity 
without help. Finally their general QOL was 51.7%, 66.7% neither good nor bad & 60% moderately good. The 
above finding for the overall patients with both mastectomy and lumpectomy, mastectomy cases only & 
lumpectomy cases only respectively. 
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Table 4: 
Comparative correlation result of RSCL (physical, psychological, activity level impairment & general 
QOL) among patients with mastectomy versus lumpectomy (n=60); (30/each). 
 
Correlation variables  
Mastectomy & Lumpectomy 
Cases overall (n=60) 
Mastectomy Cases 
only (n=30) 
Lumpectomy Cases 
only (n=30) 
Total score of  
RSCL 
Total score of RSCL Total score of  
RSCL 
-Age -.047 -.189 -079 
-Since when had cancer -.077 -.376* .147 
-Chemotherapy total 
score 
-.066 .103 -.25* 
-Other taken medications 
total score  
  .304* .287* .323* 
-Physical total score      .826** .829* .828** 
-Psychological total score      .705** .747** .668** 
-Activity Level 
impairment total score  
                      -.201 -.150 -.251* 
Comparative correlation results revealed that there was difference of finding in relation to total score of 
RSCL & (since when patients had cancer, chemotherapy total score, other medications total score (zofran, 
zantac, decadron & avil,) physical total score & psychological total score) and this was between "mastectomy & 
lumpectomy cases overall, the mastectomy cases only and the lumpectomy cases only" as follows: A negative 
moderate correlation between total score of RSCL and since when had cancer = -.376 for mastectomy cases only. 
And there was a negative weak correlation= -.25 between RSCL total score of lumpectomy cases and 
chemotherapy total score Also there was a moderate correlation between total score of RSCL and other 
medications total score= .304, .287 & .323 for the patients with mastectomy and lumpectomy overall cases, 
mastectomy cases only & lumpectomy cases only respectively. While there was a perfect correlation between 
total score of RSCL and physical total score =.826, .829 & .828 for the patients with mastectomy and 
lumpectomy overall cases, mastectomy cases only & lumpectomy cases only respectively. In addition the study 
revealed that there was a strong correlation between the RSCL total score and psychological total score=.705, 
.747 & .668 for the patients with mastectomy and lumpectomy overall cases, mastectomy cases only & 
lumpectomy cases only respectively. Finally there was a negative weak correlation between RSCL total score 
and Activity Level impairment total score= -.251 for the patients with lumpectomy cases only. 
  
Discussion 
The research aim was to compare the Symptoms-related distress among patients receiving adjuvant therapy: 
radical mastectomy versus lumpectomy at a university hospital. regarding the social characteristics the current 
study  revealed that nearby half of the mastectomy and lumpectomy patients' age was between forty and fifty 
years old; a study conducted by Rezende (2016) congruent with the current research finding as it reported that 
59% of a survey study on 500 women who had mastectomy their age ranged between 40-59 years old; whereas 
for the lumpectomy sample around one third of them their age was between forty and fifty years old; while the 
other third of them was ranged between fifty and sixty years old. However the both studied groups (mastectomy 
& lumpectomy) cases their mean of age was almost matched and this was expected as the sample groups were 
homogenous.  Concerning their marital status was found that the majority of the sample was married for both 
mastectomy and lumpectomy sample. Also the patients' education who could read and write was more than one 
third of the mastectomy sample versus around quarter of the lumpectomy sample. Relating to the majority of 
mastectomy and lumpectomy patients was house wife. Also the majority of mastectomy and lumpectomy 
patients were living with not less than three members at one place. A study done by Nascimento, Fonsêca, 
Andrade, Leite, Zaccara, da Costa (2014) for patients with preoperative breast cancer revealed that regarding the 
educational level, (14%) were illiterate, (57%) had incomplete primary education and two (29%) with higher 
education. The family income was less than the minimum wage for (14%) women. 
Concerning patients' period of having cancer it was around two third of the mastectomy sample and 
more than one third of the lumpectomy sample was between 6->12 (Months); which reflected that the breast 
cancer became more advanced for patients with mastectomy until they figured out that they have breast cancer 
and it needed medical/surgical intervention and/or the waiting list which might take sometimes. And this 
congruent with Cancer Research UK (2016) as they mentioned to take the mastectomy decision it might depend 
on several patients' breast condition as follows "The size of the cancer in the breasts, whether it has spread to any 
other part of the body, the size of breasts and the personal wishes and feelings" 
While for the taken chemotherapy it was more than half of the mastectomy patients and around half of 
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the lumpectomy patients were taking taxol. This finding was anticipated as Beaumont (2016) reported that in 
April of 1994, the FDA approved taxol for the treatment of metastatic breast cancer that did not respond to 
combination chemotherapy or breast cancer that had recurred within 6 months after the completion of initial 
chemotherapy. And this go on the same line of the current study as the study sample had another 
chemotherapeutic agents as (Doxorobcin, -5-Flurouracil; ….etc) in addition to taxol. And beside the 
chemotherapy there was other taken medication as anti-inflammatory, antacid….etc and it was recorded in the 
current study that the majority of both mastectomy and lumpectomy sample was taken zantac; which has a 
definite impact on block the histamine H2-receptor antagonist that inhibits gastric acid production as these 
patients categories are under psychological effect as they were hospitalized, had cancer and also was performed 
either mastectomy or lumpectomy surgical management. On the other hand the antacid could manage the 
physical effect which was as a result of the taken chemotherapeutic and anti-inflammatory medications which 
cause direct negative effect on the gastrointestinal system (GIT) generally and GIT mucosal tissue specifically.  
Ignoffo (2016) reported that taking zantac is highly effective in "preventing chemotherapy toxicities" nausea and 
vomiting are common side effects of chemotherapy drugs which are used to treat cancer. In almost cases, 
patients will be given anti-vomiting (antiemetic) and anti-nausea medication during administering 
chemotherapeutic course. 
Patients' physical result was observed as the majority of the mastectomy sample was at the level of quite 
a bit versus more than half of the lumpectomy sample. Which means that patients with mastectomy suffered 
physically more than lumpectomy patients as quite a bit level was equal to the third level of the scale 
measurement; and this finding was significantly expected as removal of the breast with its lymphatic vessels was 
causing a physical burden higher than the lumpectomy procedure; these physical problems was as nausea, 
vomiting, headache, low back pain…etc. The following studies finding agreed with the current research finding; 
as a study done by Rahman, Ahsan, Monalisa & Rahman (2014) congruent with the current research finding as it 
reported that significant reduction of the scores found with means deterioration of function in physical well-
being for patients with mastectomy and even they found that younger age group patients expressed much 
distress. Comparing to result reported by Land, Kopec, Julian, Brown, Anderson, Krag, Christian, Costantino, 
Wolmark & Ganz (2010) on a Longitudinal study done for patients with lumpectomy who revealed that patients 
were more likely to experience arm and breast symptoms, restricted work and social activity, and impaired QOL 
(P < or = .002 all items); from 12 to 36 months. 
Also for the psychological result was found that more than half of the mastectomy cases were also at 
the level of quite a bit which was at the third level comparing to more than half of the lumpectomy cases at the 
level of a little which ranked at the second level. The psychological problems were as decreased sexual interest, 
difficulty sleeping, depressed mood…etc. The researchers interpreted that as the psychological problems for the 
lumpectomy category was much tolerated more than for the mastectomy patients. Moreover Nweze & Maureen 
(2012) after analyzing fifteen research articles that  investigated the psychological impact of mastectomy and 
breast reconstruction patients; found that the most common psychological impact of mastectomy and breast 
cancer was low self-esteem, altered sexuality, and poor quality of life.  
Concerning total RSCL the study revealed that the majority for both the mastectomy and lumpectomy 
cases was at the level of quite a bit as well. Actually same finding was cited by Schubart, Emerich, Farnan, 
Stanley, Kauffman & Kass (2014) as they mentioned in their research that high levels of distress in all domains 
associated with younger age and was for more extensive surgery (bilateral mastectomy versus unilateral 
mastectomy versus lumpectomy). Moreover in the current study the researchers found that activity of patients' 
level impairment was nearby half of the mastectomy patients could do the activity but with help but more than 
one third of the lumpectomy patients could do the activity without help. Lastly their general QOL was rated that 
two third of the mastectomy cases was neither good nor bad while more than half of the lumpectomy cases was 
moderately good. Cleeland, Mayer, Dreyer, Yim, Yu, Su, Mun, Sloan & Kaufman. (2014) reported that Limited 
data exist on the association of symptom burden, daily activity impairment, and work productivity in patients 
with advanced breast cancer and at the same time they figured out in their study that fatigue, decreased sexual 
interest, disturbed sleep, emotional distress, and drowsiness were the most common severe symptoms, and were 
of moderate-to-severe intensity in 38.8%-52.0% of the studied patients. 
Comparing between correlation results for the both group mastectomy versus lumpectomy revealed that 
there was relation in some finding as follows:  
There was a weak correlation between RSCL total score of lumpectomy cases and chemotherapy total 
score; while there was a moderate correlation between total score of RSCL and other medications total score for 
the patients with the overall cases, mastectomy cases only & lumpectomy cases only respectively. Actually it 
was strange to find even a weak correlation between the chemotherapeutic agents and the lumpectomy category. 
But from the researchers' point of view it was as much as the period of cancer increasing as much as patients 
with breast cancer will be under stress. And it was hardly to find a research conducted in this point but a study 
was found by Tatrow, Montgomery, Avellino & Bovbjerg (2004) which was matched with what reported in the 
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current study; as it was emphasized the importance of investigation of potential targets for distress-reducing 
interventions. Although apparently the taken medication of chemotherapy and other medications as antacid or 
anti-inflammatory put both patients with mastectomy and lumpectomy under symptoms distress because of its 
physical side effects and it alleviates their psychological distress symptoms as chemotherapy is well known 
about its body image disturbance as loss of hair…etc. prolonged anti-inflammatory increases gastro-intestinal 
problems. At the same line another recent study was conducted by Traeger, McDonnell, McCarty, Greer, El-
Jawahri & Temel (2015) which supported the current research finding as they found that 50.8% of their 
participants reported ≥1 physical symptom, most commonly lack of energy (35.8%) and drowsiness (30.8%). 
And a randomized group interacted with emetogenic potential in predicting symptom distress (γ = 0.43; P = .03 
and they recommended that early symptoms highlight the importance of continuing to examine strategies to 
improve symptom management during chemotherapy for nonmetastatic cancer disease. 
While there was a perfect correlation between total score of RSCL and physical total score for the 
patients with the overall cases, mastectomy cases only & lumpectomy cases only. Also the study revealed that 
there was a strong correlation between the RSCL total score and psychological total score for the patients with 
the overall cases, mastectomy cases only & the lumpectomy cases only. The researchers interpreted that finding 
as both patients with mastectomy or lumpectomy surgical manipulation would cause a stressful impact on breast 
cancer patients on the physical and psychological levels; specially that those patients were undertaken adjuvant 
chemotherapeutic treatment after the surgical management which increased their physical and psychological 
negative complaining in relation to the overall related distress symptoms. Regarding the physical finding a study 
be in agreement with the current research finding as Bränström, Petersson, Saboonchi, Wennman-Larsen, 
Alexanderson (2015) reported that Less than one third of the participants in their study were sufficiently 
physically active at baseline; however physical activity decreased after surgery and increased at 8 month follow-
up, and subsequently decreased slightly during the subsequent follow-up period. They explained that physical 
changing as physical inactivity was related to a reducing in the health, increased symptoms such as pain, 
depression, and anxiety. In addition and related to the psychological finding a similar study conducted by 
Bencová, Bella & Svec (2011) congruent with the current research finding as they revealed that intensity of 
psychological dysfunction symptoms in breast cancer patients (Modified radical mastectomy, breast-conserving 
surgery/lumpectomy) required greater attention related to the need for appropriate community-based 
psychosocial interventions and psychosocial prevention due to the negative impact of continuing and even 
accelerated psycho-social distress on the quality of life of surviving patients. 
Once the mastectomy has been performed, the woman suffers too much due to the physical change 
which she has experienced, however the psychological pain can sometimes be hidden behind another element 
such as the fear of disease and its possibility of reappearance. Same drawback affects the patients with 
lumpectomy management but from different side as they have kind of overwhelming of having mastectomy in 
the future. So identifying symptoms related distress for both mastectomy and lumpectomy cases at one study was 
valuable not only for the magnitude of nursing body of knowledge but also to find out the symptoms distress for 
each different breast cancer management and to map the nursing care while dealing with different breast cancer 
patients category; especially for those patients who are receiving adjuvant therapy following the surgical 
management.   
 
Conclusion of the study 
In conclusion; the study results answered the two recommended research questions which have been revealed 
that there was a difference between mastectomy and lumpectomy studied cases in relation to RSCL and 
(chemotherapy, other taken medication as zantac, decadron,…etc, physical & psychological) total score. And 
apparently the lumpectomy cases scored generally their physical, psychological & activity level impairment 
status much better than the mastectomy cases. Also lumpectomy cases their general QOl was better than the 
mastectomy cases.  
  
Recommendation of the study:  
1-More close physical, psychological support must endorsed in nursing care    
    for patients with mastectomy. 
2- Further studies is recommended to examine the physical & psychological  
    health status for both mastectomy & lumpectomy cases. 
3-QOL advanced tool is recommended on survey scale to evaluate patients;  
    condition with mastectomy & lumpectomy. 
4-All patients with breast cancer must join a rehabilitation program before &  
    after proceeding in either mastectomy or lumpectomy surgical management. 
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Nursing Implication of the study 
The utilized tool was very clear and objective oriented which could enable the nurse to use it in chemotherapy 
cycle base to evaluate the patients' physical, psychological condition in order to limit their QOL deterioration 
and to enroll the patients in physical & psychological health program.  
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